Quantcast
Channel: cafepharma - chronic lymphocytic leukemia
Browsing latest articles
Browse All 43 View Live

This Small Company Is Winning the War Against Blood Cancer

This Small Company Is Winning the War Against Blood Cancer Motley Fool

View Article



FDA grants priority review to blood cancer treatment from Pharmacyclics

FDA grants priority review to blood cancer treatment from Pharmacyclics Yahoo/AP

View Article

Breakthrough status for GSK and Genmab leukemia drug

Breakthrough status for GSK and Genmab leukemia drug Pharma Times, UK

View Article

Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? Motley Fool

View Article

GSK and Genmab Announce European Submission to Regulatory Authorities for...

GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) Yahoo/Globe Newswire

View Article


Gilead Stops Leukemia Drug Trial Early on Patient Benefit

Gilead Stops Leukemia Drug Trial Early on Patient Benefit Bloomberg

View Article

GSK/Genmab file Arzerra for first-line CLL

GSK/Genmab file Arzerra for first-line CLL Pharma Times, UK

View Article

FDA approves Roche leukemia drug Gazyva

FDA approves Roche leukemia drug Gazyva Reuters

View Article


Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation

Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation Motley Fool

View Article


Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or...

Gilead’s Idelalisib Significantly Reduces Rate of Disease Progression or Death in Phase 3 Chronic Lymphocytic Leukemia Study Yahoo

View Article

Ditching Big Drugmakers for Biotech Brings Leukemia Boon

Ditching Big Drugmakers for Biotech Brings Leukemia Boon Bloomberg

View Article

Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated...

Gilead Announces Interim Phase 2 Results for GS-9973 in Previously Treated Chronic Lymphocytic Leukemia Yahoo/BusinessWire

View Article

New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential

New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential Bloomberg

View Article


Pharmacyclics Shares Rise on Positive Leukemia Trial

Pharmacyclics Shares Rise on Positive Leukemia Trial Bloomberg

View Article

J&J, Pharmacyclics drug gets U.S. approval for leukemia

J&J, Pharmacyclics drug gets U.S. approval for leukemia Yahoo/Reuters

View Article


Pharmacyclics Drug Imbruvica Beats Rivals: Nomura

Pharmacyclics Drug Imbruvica Beats Rivals: Nomura Investors.com

View Article

3 Breakthrough Drugs Yield 1 Instant Blockbuster

3 Breakthrough Drugs Yield 1 Instant Blockbuster Motley Fool

View Article


AbbVie Presents New Results from Studies of Investigational Oncology Compound...

AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting Yahoo/PR NewsWire

View Article

FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer

FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer Yahoo/AP

View Article

FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications

FDA Grants Regular (Full) Approval for IMBRUVICA® for Two Indications Marketwatch

View Article
Browsing latest articles
Browse All 43 View Live




Latest Images